Alpha BreakingAlpha Breaking
Bullish Sentiment

Precisepk Marks 40+ Years of Precision Dosing - Oct 20

2 min readTuesday, October 20, 2026 at 12:04 PM ET
Precisepk Marks 40+ Years of Precision Dosing - Oct 20

Share this article

Spread the word on social media

The Story

PrecisePK, a therapeutic drug monitoring software company, marked more than 40 years of precision dosing in a PR Newswire release dated Oct. 20, 2026 from San Diego. The company said its platform now connects directly to Epic, Cerner and Sentri7 so patient data flows to clinicians and pharmacists, freeing more time for patient care.

Why It Matters For Your Portfolio

  • 40+ years of operating history, signaling sustained product depth and institutional relationships, which may support steady enterprise adoption of TDM software.
  • Direct EHR integrations with Epic, Cerner and Sentri7, a technical advance that could speed clinician access to TDM data and reduce manual workflow time, potentially improving customer retention.
  • Workflow and safety focus targets pharmacist efficiency, which data suggests can reduce errors and operational costs for hospitals and health systems that adopt the software.
  • Investors tracking health IT and hospital software may want to watch larger EHR vendor activity, including public companies tied to EHR markets such as $ORCL, for partnership or integration signals.

The Trade

Growth investors and health IT watchers should note this as an operational milestone rather than a direct earnings event; the update emphasizes integrations that could support sales momentum. Keep an eye on future adoption announcements, customer rollout details, and any partnership updates from PrecisePK or major EHR vendors as the next catalysts for measurable commercial impact.

PrecisePK Marks 40+ Years of Precision Dosing, Highlights EHR Integrations Driving Safer Pharmacist WorkflowsPrecisePKEHR integrationsTDM softwarepharmacist workflows

Trade this headline in Alpha Contests.

Free practice contests — earn Alpha Coins
Enter a Contest

Stay Ahead of the Market

Get breaking news on trending finance topics delivered as they happen. We find the stories others miss.

More Breaking News

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.